loadpatents
name:-0.026780843734741
name:-0.021065950393677
name:-0.015583038330078
Weiskopf; Kipp Andrew Patent Filings

Weiskopf; Kipp Andrew

Patent Applications and Registrations

Patent applications and USPTO patent grants for Weiskopf; Kipp Andrew.The latest application filed is for "cd47 targeted therapies for the treatment of infectious disease".

Company Profile
16.18.24
  • Weiskopf; Kipp Andrew - Sudbury MA
  • Weiskopf; Kipp Andrew - Brookline MA
  • Weiskopf; Kipp Andrew - Menlo Park CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling
Grant 11,419,897 - Shizuru , et al. August 23, 2
2022-08-23
Cd47 Targeted Therapies For The Treatment Of Infectious Disease
App 20220098322 - Weiskopf; Kipp Andrew ;   et al.
2022-03-31
High Affinity Sirp-alpha Reagents And Methods Of Using
App 20220064293 - Ring; Aaron Michael ;   et al.
2022-03-03
CD47 targeted therapies for the treatment of infectious disease
Grant 11,230,607 - Weiskopf , et al. January 25, 2
2022-01-25
High affinity SIRP-alpha reagents and methods of using
Grant 11,208,481 - Ring , et al. December 28, 2
2021-12-28
Use of anti-CD47 agents to enhance immunization
Grant 11,154,600 - Tseng , et al. October 26, 2
2021-10-26
Targeted Therapy For Small Cell Lung Cancer
App 20210277115 - Weiskopf; Kipp Andrew ;   et al.
2021-09-09
Targeted therapy for small cell lung cancer
Grant 11,046,763 - Weiskopf , et al. June 29, 2
2021-06-29
Compositions And Methods For Inducing Phagocytosis Of Mhc Class I Positive Cells And Countering Anti-cd47/sirpa Resistance
App 20210101985 - Maute; Roy Louis ;   et al.
2021-04-08
Enhanced Depletion Of Targeted Cells With Cd47 Blockade And An Immune Costimulatory Agonist
App 20210095034 - Schnorr; Peter J. ;   et al.
2021-04-01
Enhanced depletion of targeted cells with CD47 blockade and an immune costimulatory agonist
Grant 10,894,831 - Schnorr , et al. January 19, 2
2021-01-19
Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistance
Grant 10,889,649 - Maute , et al. January 12, 2
2021-01-12
Cd47 Targeted Therapies For The Treatment Of Infectious Disease
App 20200354469 - Weiskopf; Kipp Andrew ;   et al.
2020-11-12
Anti SIRP-.alpha. antibodies and bi-specific macrophage enhancing antibodies
Grant 10,781,256 - Weiskopf , et al. Sept
2020-09-22
CD47 targeted therapies for the treatment of infectious disease
Grant 10,723,803 - Weiskopf , et al.
2020-07-28
Enhanced Depletion Of Targeted Cells With Cd47 Blockade And An Immune Costimulatory Agonist
App 20200223923 - Schnorr; Peter ;   et al.
2020-07-16
Engraftment Of Stem Cells With A Combination Of An Agent That Targets Stem Cells And Modulation Of Immunoregulatory Signaling
App 20200129557 - Shizuru; Judith A. ;   et al.
2020-04-30
Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling
Grant 10,406,179 - Shizuru , et al. Sept
2019-09-10
Compositions And Methods For Inducing Phagocytosis Of Mhc Class I Positive Cells And Countering Anti-cd47/sirpa Resistance
App 20190241664 - Maute; Roy Louis ;   et al.
2019-08-08
High affinity CD47 analogs
Grant 10,358,472 - Ho , et al. July 23, 2
2019-07-23
Compositions and methods for inducing phagocytosis of MHC class I positive cells and countering anti-CD47/SIRPA resistance
Grant 10,316,094 - Maute , et al.
2019-06-11
Cd47 Targeted Therapies For The Treatment Of Infectious Disease
App 20190092873 - Weiskopf; Kipp Andrew ;   et al.
2019-03-28
CD47 targeted therapies for the treatment of infectious disease
Grant 10,184,004 - Weiskopf , et al. Ja
2019-01-22
Use Of Anti-cd47 Agents To Enhance Immunization
App 20180353582 - Tseng; Diane ;   et al.
2018-12-13
Anti SIRP-alpha Antibodies and Bi-specific Macrophage Enhancing Antibodies
App 20180319883 - Weiskopf; Kipp Andrew ;   et al.
2018-11-08
Anti-SIRP-alpha antibodies and bispecific macrophage enhancing antibodies
Grant 10,081,680 - Weiskopf , et al. September 25, 2
2018-09-25
Compositions And Methods For Inducing Phagocytosis Of Mhc Class I Positive Cells And Countering Anti-cd47/sirpa Resistance
App 20180251558 - Maute; Roy Louis ;   et al.
2018-09-06
Use of anti-CD47 agents to enhance immunization
Grant 10,064,925 - Tseng , et al. September 4, 2
2018-09-04
High Affinity Sirp-alpha Reagents And Methods Of Using
App 20180195054 - Ring; Aaron Michael ;   et al.
2018-07-12
High Affinity Cd47 Analogs
App 20180127480 - Ho; Chia Chi ;   et al.
2018-05-10
High affinity Sirp-alpha reagents and methods of using
Grant 9,944,911 - Ring , et al. April 17, 2
2018-04-17
Methods for determining responsiveness to an anti-CD47 agent
Grant 9,945,870 - Weiskopf , et al. April 17, 2
2018-04-17
Cd47 Targeted Therapies For The Treatment Of Infectious Disease
App 20170362332 - Weiskopf; Kipp Andrew ;   et al.
2017-12-21
CD47 targeted therapies for the treatment of infectious disease
Grant 9,771,428 - Weiskopf , et al. September 26, 2
2017-09-26
Engraftment Of Stem Cells With A Combination Of An Agent That Targets Stem Cells And Modulation Of Immunoregulatory Signaling
App 20170224737 - Shizuru; Judith A. ;   et al.
2017-08-10
Macrophage Or Monocyte Enhanced Wound Healing
App 20170157296 - Walmsley; Graham G. ;   et al.
2017-06-08
Anti SIRP-alpha Antibodies and Bi-specific Macrophage Enhancing Antibodies
App 20170073414 - Weiskopf; Kipp Andrew ;   et al.
2017-03-16
Targeted Therapy for Small Cell Lung Cancer
App 20160333093 - Weiskopf; Kipp Andrew ;   et al.
2016-11-17
Use of Anti-CD47 Agents to Enhance Immunization
App 20160144009 - Tseng; Diane ;   et al.
2016-05-26
Methods for Determining Responsiveness to an Anti-CD47 Agent
App 20160069898 - Weiskopf; Kipp Andrew ;   et al.
2016-03-10
CD47 Targeted Therapies for the Treatment of Infectious Disease
App 20150376288 - Weiskopf; Kipp Andrew ;   et al.
2015-12-31
High Affinity Sirp-Alpha Reagents
App 20150071905 - Ring; Aaron Michael ;   et al.
2015-03-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed